Catalyst Wire Dossier Catalyst Wire Dossier

rhIFNα nasal drops

recombinant human interferon alpha nasal drops
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhIFNα nasal drops, covering 2020-03-31 to 2020-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff [Phase 3]

See pricing